Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?

Ther Adv Med Oncol · 2021 · PMC8543684 · PMID 34707693

Europe PMC DOI

hedged sentence

0.0140

closest p · 0.3× alpha

0.0140

boldest claim

The sentences

showed a trendp = 0.0140actually significant

Freedom from distance metastasis also showed a trend for benefit at 5 years (91.7% versus 94.4% versus 95.2%), with a significant reduction for the triple modality arm ( p = 0.0140) compared to baseline, but without any significant differences in OS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.